Creative Planning
ANIK icon

Creative Planning’s Anika Therapeutics ANIK Stock Holding History

Creative Planning’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,262
Closed -$325K – 1872
2019
Q4 		$325K Buy
6,262
+8
+0.1% +$465 ﹤0.01% 1361
2019
Q3 		$343K Sell
6,254
-8,944
-59% -$459K ﹤0.01% 1275
2019
Q2 		$617K Hold
15,198
– – ﹤0.01% 962
2019
Q1 		$460K Buy
15,198
+1,290
+9% +$44.2K ﹤0.01% 1080
2018
Q4 		$467K Buy
13,908
+3,704
+36% +$134K ﹤0.01% 1001
2018
Q3 		$430K Hold
10,204
– – ﹤0.01% 1179
2018
Q2 		$327K Sell
10,204
-13
-0.1% -$535 ﹤0.01% 1322
2018
Q1 		$508K Buy
10,217
+1,988
+24% +$112K ﹤0.01% 1074
2017
Q4 		$444K Buy
+8,229
New +$455K ﹤0.01% 1148
2017
Q3 		– Sell
-1,004
Closed -$50K – 1965
2017
Q2 		$50K Sell
1,004
-50
-5% -$2.3K ﹤0.01% 2504
2017
Q1 		$46K Buy
1,054
+50
+5% +$2.39K ﹤0.01% 2532
2016
Q4 		$49K Buy
1,004
+4
+0.4% +$185 ﹤0.01% 2402
2016
Q3 		$48K Sell
1,000
-86
-8% -$4.25K ﹤0.01% 2389
2016
Q2 		$58K Sell
1,086
-414
-28% -$19.5K ﹤0.01% 2030
2016
Q1 		$67K Buy
1,500
+200
+15% +$8.11K ﹤0.01% 1892
2015
Q4 		$50K Buy
1,300
+300
+30% +$11.5K ﹤0.01% 2118
2015
Q3 		$32K Buy
+1,000
New +$34.9K ﹤0.01% 2365
2015
Q2 		– Sell
-1,000
Closed -$41K – 1185
2015
Q1 		$41K Hold
1,000
– – ﹤0.01% 2153
2014
Q4 		$41K Sell
1,000
-22
-2% -$860 ﹤0.01% 2135
2014
Q3 		$37K Buy
1,022
+22
+2% +$951 ﹤0.01% 2126
2014
Q2 		$46K Hold
1,000
– – ﹤0.01% 1921
2014
Q1 		$41K Sell
1,000
-300
-23% -$11.2K ﹤0.01% 1927
2013
Q4 		$50K Sell
1,300
-518
-28% -$16K ﹤0.01% 1605
2013
Q3 		$43K Buy
1,818
+818
+82% +$18.4K ﹤0.01% 1598
2013
Q2 		$17K Buy
+1,000
New +$14.4K ﹤0.01% 2015

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Creative Planning's ANIK Position: Q1 2020 in Review

Creative Planning sold out of Anika Therapeutics (ANIK) in Q1 2020, closing a stake of 6,262 shares — an estimated $325K sold.

Creative Planning first reported a position in ANIK in Q2 2013 and held it in 25 quarters. The position peaked at $617K in Q2 2019. 163 funds tracked by Wall St. Rank hold ANIK as of Q1 2020.

  • Creative Planning reported no remaining Anika Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Creative Planning sold 6,262 Anika Therapeutics shares in Q1 2020, an estimated $325K.
  • Creative Planning first reported a position in Anika Therapeutics in Q2 2013 and held it in 25 quarters.
  • Creative Planning's Anika Therapeutics position peaked at $617K in Q2 2019.
  • 163 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2020.

Based on Creative Planning's 13F filing for Q1 2020, filed 5 May 2020.